Improved functionalization of oleic acid-coated iron oxide nanoparticles for biomedical applications

Superparamagnetic iron oxide nanoparticles can providemultiple benefits for biomedical applications in aqueous environments such asmagnetic separation or magnetic resonance imaging. To increase the colloidal stability and allow subsequent reactions, the introduction of hydrophilic functional groups onto the particles’ surface is essential. During this process, the original coating is exchanged by preferably covalently bonded ligands such as trialkoxysilanes. The duration of the silane exchange reaction, which commonly takes more than 24 h, is an important drawback for this approach. In this paper, we present a novel method, which introduces ultrasonication as an energy source to dramatically accelerate this process, resulting in high-quality waterdispersible nanoparticles around 10 nmin size. To prove the generic character, different functional groups were introduced on the surface including polyethylene glycol chains, carboxylic acid, amine, and thiol groups. Their colloidal stability in various aqueous buffer solutions as well as human plasma and serum was investigated to allow implementation in biomedical and sensing applications.status: publishe

Impact of two PEEP titration strategies in a swine model of acute respiratory distress syndrome: guided by esophageal pressure versus guided by electrical impedance tomography

INTRODUÇÃO: O uso de níveis elevados da pressão expiratória final positiva (PEEP) na Síndrome do desconforto respiratório agudo (SDRA), visando reduzir a quantidade de pulmão colapsado, tornando a ventilação mais homogênea, tem sido apontado por estudos clínicos randomizados e metaanálises como uma estratégia eficaz na melhora de alguns desfechos clínicos. Atualmente, não existe um método ideal para ajuste da PEEP na SDRA. Dois métodos distinguem-se pela racionalidade fisiológica e possibilidade de serem usados na prática clínica usual: ajuste da PEEP guiado por Pressão Esofágica (Pes) e ajuste da PEEP guiado por Tomografia de Impedância Elétrica (TIE). Os objetivos do estudo foram: (1) Avaliar, através de tomografia computadorizada de tórax (raios X), qual estratégia induz uma melhor aeração pulmonar: maior recrutamento pulmonar e menor hiperdistensão; (2) Avaliar as alterações da distribuição regional da ventilação, do volume pulmonar e da complacência regional medidos pela tomografia de impedância elétrica; (3) Avaliar as alterações na mecânica pulmonar e nas trocas gasosas produzidas por ambas as estratégias de titulação da PEEP. MÉTODOS: Dez porcos foram submetidos a um modelo de SDRA grave: depleção de surfactante mais lesão pulmonar induzida pelo ventilador. Após uma manobra de recrutamento (MR), duas estratégias de titulação da PEEP foram testadas em uma sequência aleatória: 1) Utilizando a tomografia por impedância elétrica para calcular a menor PEEP que mantem um colapso pulmonar menor de 1%; 2) Utilizando a pressão esofágica para calcular a PEEP necessária para atingir uma pressão transpulmonar final expiratória (PLexp) entre 5-6 cmH2O. Em seguida, os animais foram ventilados durante 1 hora com a PEEP ótima estimada por cada método. Foram registrados parâmetros fisiológicos e de tomografia computadorizada (TC) antes da MR (tempo basal) e após ventilação com a PEEP ótima (15 min e 60 min). RESULTADOS: Aos 60 min, ambas as estratégias reduziram o colapso pulmonar, mas com efeitos significativamente maiores (P 0,05). O tecido hiperaerado e a hipedistensão cíclica foram baixos em ambos os grupos. CONCLUSÕES: Neste modelo animal de SDRA grave o ajuste da PEEP guiado por TIE produz um maior recrutamento pulmonar e sinais fisiológicas de melhor proteção pulmonar quando comparado com o ajuste da PEEP guiado por PesINTRODUCTION: The use of higher levels of positive end-expiratory pressure (PEEP) in the acute respiratory distress syndrome (ARDS), aimed at reducing the amount of lung collapse, making the ventilation more homogeneous, has been pointed out by randomized clinical trials and meta-analysis as an effective strategy to improve some clinical outcomes. Currently, there is no ideal method for adjustment PEEP in ARDS. Two methods are distinguished by their physiological rationality and the possibility of being used in the clinical practice: PEEP titration guided by Esophageal Pressure (Pes) and PEEP titration guided by Electrical Impedance Tomography (EIT). The objectives of the study were: 1) To evaluate through computed tomography of thorax (X-ray), which strategy induces better pulmonary aeration: greater lung recruitment and less hyperdistension; (2) To evaluate changes in the regional distribution of ventilation, pulmonary volume and regional compliance, measured by electrical impedance tomography; (3) To assess changes in lung mechanics and gas exchange produced by both PEEP titration strategies. METHODS: Ten pigs were submitted to a two-hit model of severe ARDS: Surfactant depletion plus ventilator-induced lung injury. After a recruitment maneuver (RM), two strategies of PEEP titration were tested in a randomized sequence: 1) Using electric impedance tomography to calculate the lowest PEEP keeping recruitable-lungcollapse 0.05). Hyperaerated tissue and tidal hyperinflation were very low in both groups. CONCLUSION: In this model, the choice of PEEP guided by EIT leads to higher lung recruitment and physiological signals of a better lung protection, when compared to the strategy guided by Pe

Sequential lateral positioning as a new lung recruitment maneuver : an exploratory study in early mechanically ventilated Covid-19 ARDS patients

Background: A sequential change in body position from supine-to-both lateral positions under constant ventilatory settings could be used as a postural recruitment maneuver in case of acute respiratory distress syndrome (ARDS), provided that sufficient positive end-expiratory pressure (PEEP) prevents derecruitment. This study aims to evaluate the feasibility and physiological effects of a sequential postural recruitment maneuver in early mechanically ventilated COVID-19 ARDS patients. Methods: A cohort of 15 patients receiving lung-protective mechanical ventilation in volume-controlled with PEEP based on recruitability were prospectively enrolled and evaluated in five sequentially applied positions for 30 min each: Supine-baseline; Lateral-1st side; 2nd Supine; Lateral-2nd side; Supine-final. PEEP level was selected using the recruitment-to-inflation ratio (R/I ratio) based on which patients received PEEP 12 cmH(2)O for R/I ratio <= 0.5 or PEEP 15 cmH(2)O for R/I ratio > 0.5. At the end of each period, we measured respiratory mechanics, arterial blood gases, lung ultrasound aeration, end-expiratory lung impedance (EELI), and regional distribution of ventilation and perfusion using electric impedance tomography (EIT). Results: Comparing supine baseline and final, respiratory compliance (29 +/- 9 vs 32 +/- 8 mL/cmH(2)O; p < 0.01) and PaO2/FlO(2) ratio (138 +/- 36 vs 164 +/- 46 mmHg; p < 0.01) increased, while driving pressure (13 +/- 2 vs 11 +/- 2 cmH(2)O; p < 0.01) and lung ultrasound consolidation score decreased [5 (4-5) vs 2 (1-4); p < 0.01]. EELI decreased ventrally (218 +/- 205 mL; p < 0.01) and increased dorsally (192 +/- 475 mL; p = 0.02), while regional compliance increased in both ventral (11.5 +/- 0.7 vs 12.9 +/- 0.8 mL/cmH(2)O;p< 0.01 ) and dorsal regions (17.1 +/- 1.8 vs 18.8 +/- 1.8 mL/cmH(2)O; p < 0.01). Dorsal distribution of perfusion increased (64.8 +/- 7.3% vs 66.3 +/- 7.2%; p = 0.01). Conclusions: Without increasing airway pressure, a sequential postural recruitment maneuver improves global and regional respiratory mechanics and gas exchange along with a redistribution of EELI from ventral to dorsal lung areas and less consolidation

Establishment of a prospective cohort of mechanically ventilated patients in five intensive care units in Lima, Peru: protocol and organisational characteristics of participating centres

Introduction Mechanical ventilation is a cornerstone in the management of critically ill patients worldwide; however, less is known about the clinical management of mechanically ventilated patients in low and middle income countries where limitation of resources including equipment, staff and access to medical information may play an important role in defining patient-centred outcomes. We present the design of a prospective, longitudinal study of mechanically ventilated patients in Peru that aims to describe a large cohort of mechanically ventilated patients and identify practices that, if modified, could result in improved patient-centred outcomes and lower costs. Methods and analysis Five Peruvian intensive care units (ICUs) and the Medical ICU at the Johns Hopkins Hospital were selected for this study. Eligible patients were those who underwent at least 24 h of invasive mechanical ventilation within the first 48 h of admission into the ICU. Information on ventilator settings, clinical management and treatment were collected daily for up to 28 days or until the patient was discharged from the unit. Vital status was assessed at 90 days post enrolment. A subset of participants who survived until hospital discharge were asked to participate in an ancillary study to assess vital status, and physical and mental health at 6, 12, 24 and 60 months after hospitalisation, Primary outcomes include 90-day mortality, time on mechanical ventilation, hospital and ICU lengths of stay, and prevalence of acute respiratory distress syndrome. In subsequent analyses, we aim to identify interventions and standardised care strategies that can be tailored to resource-limited settings and that result in improved patient-centred outcomes and lower costs. Ethics and dissemination We obtained ethics approval from each of the four participating hospitals in Lima, Peru, and at the Johns Hopkins School of Medicine, Baltimore, USA. Results will be disseminated as several separate publications in different international journals

Sedation practices and clinical outcomes in mechanically ventilated patients in a prospective multicenter cohort

Abstract Objectives We sought to study the association between sedation status, medications (benzodiazepines, opioids, and antipsychotics), and clinical outcomes in a resource-limited setting. Design A longitudinal study of critically ill participants on mechanical ventilation. Setting Five intensive care units (ICUs) in four public hospitals in Lima, Peru. Patients One thousand six hundred fifty-seven critically ill participants were assessed daily for sedation status during 28 days and vital status by day 90. Results After excluding data of participants without a Richmond Agitation Sedation Scale score and without sedation, we followed 1338 (81%) participants longitudinally for 18,645 ICU days. Deep sedation was present in 98% of participants at some point of the study and in 12,942 ICU days. Deep sedation was associated with higher mortality (interquartile odds ratio (OR) = 5.42, 4.23–6.95; p < 0.001) and a significant decrease in ventilator (− 7.27; p < 0.001), ICU (− 4.38; p < 0.001), and hospital (− 7.00; p < 0.001) free days. Agitation was also associated with higher mortality (OR = 39.9, 6.53–243, p < 0.001). The most commonly used sedatives were opioids and benzodiazepines (9259 and 8453 patient days respectively), and the latter were associated with a 41% higher mortality in participants with a higher cumulative dose (75th vs 25th percentile, interquartile OR = 1.41, 1.12–1.77; p < 0.01). The overall cumulative dose of benzodiazepines and opioids was high, 774.5 mg and 16.8 g, respectively, by day 7 and by day 28; these doses approximately doubled. Haloperidol was only used in 3% of ICU days; however, the use of it was associated with a 70% lower mortality (interquartile OR = 0.3, 0.22–0.44, p < 0.001). Conclusions Deep sedation, agitation, and cumulative dose of benzodiazepines were all independently associated with higher 90-day mortality. Additionally, deep sedation was associated with less ventilator-, ICU-, and hospital-free days. In contrast, haloperidol was associated with lower mortality in our study

Premature, Opportune, and Delayed Weaning in Mechanically Ventilated Patients: A Call for Implementation of Weaning Protocols in Low- and Middle-Income Countries

Weaning protocols establish readiness-to-wean criteria to determine the opportune moment to conduct a spontaneous breathing trial. Weaning protocols have not been widely adopted or evaluated in ICUs in low- and middle-income countries. We sought to compare clinical outcomes between participants whose weaning trials were retrospectively determined to have been premature, opportune, or delayed based on when they met readiness-to-wean criteria. Prospective, multicenter observational study. Five medical ICUs in four public hospitals in Lima, Perú. Adults with acute respiratory failure and at least 24 hours of invasive mechanical ventilation (n = 1,657). None. We established six readiness-to-wean criteria and retrospectively categorized our sample into three weaning groups: 1) premature: if the weaning trial took place before fulfilling all criteria, 2) opportune: if the weaning trial took place within 24 hours after fulfilling the criteria, and 3) delayed: if the weaning trial took place over 24 hours after fulfilling criteria. We compared 90-day mortality, ventilator-free days, ICU-free days, and hospital-free days between premature, opportune, and delayed weaning groups. In our sample, 761 participants (60.8%) were classified as having a premature weaning trial, 196 underwent opportune weaning (15.7%), and 295 experienced delayed weaning (23.6%). There was no significant difference in 90-day mortality between the groups. Both the premature and delayed weaning groups had poorer clinical outcomes with fewer ventilator-free days (-2.18, p = 0.008) and (-3.49, p < 0.001), ICU-free days (-2.25, p = 0.001) and (-3.72, p < 0.001), and hospital-free days (-2.76, p = 0.044) and (-4.53, p = 0.004), respectively, compared with the opportune weaning group. Better clinical outcomes occur with opportune weaning compared with premature and delayed weaning. If readiness-to-wean criteria can be applied in resource-limited settings, it may improve ICU outcomes associated with opportune weaning

Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo

BACKGROUND: Cardiovascular (CV) disease is the leading cause of morbidity and mortality in patients with type 2 diabetes mellitus (T2DM). Furthermore, patients with T2DM and acute coronary syndrome (ACS) have a particularly high risk of CV events. The glucagon-like peptide 1 receptor agonist, lixisenatide, improves glycemia, but its effects on CV events have not been thoroughly evaluated. METHODS: ELIXA (www.clinicaltrials.gov no. NCT01147250) is a randomized, double-blind, placebo-controlled, parallel-group, multicenter study of lixisenatide in patients with T2DM and a recent ACS event. The primary aim is to evaluate the effects of lixisenatide on CV morbidity and mortality in a population at high CV risk. The primary efficacy end point is a composite of time to CV death, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for unstable angina. Data are systematically collected for safety outcomes, including hypoglycemia, pancreatitis, and malignancy. RESULTS: Enrollment began in July 2010 and ended in August 2013; 6,068 patients from 49 countries were randomized. Of these, 69% are men and 75% are white; at baseline, the mean ± SD age was 60.3 ± 9.7 years, body mass index was 30.2 ± 5.7 kg/m(2), and duration of T2DM was 9.3 ± 8.2 years. The qualifying ACS was a myocardial infarction in 83% and unstable angina in 17%. The study will continue until the positive adjudication of the protocol-specified number of primary CV events. CONCLUSION: ELIXA will be the first trial to report the safety and efficacy of a glucagon-like peptide 1 receptor agonist in people with T2DM and high CV event risk

Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo

Background: Cardiovascular (CV) disease is the leading cause of morbidity and mortality in patients with type 2 diabetes mellitus (T2DM). Furthermore, patients with T2DM and acute coronary syndrome (ACS) have a particularly high risk of CV events. The glucagonlike peptide 1 receptor agonist, lixisenatide, improves glycemia, but its effects on CV events have not been thoroughly evaluated. Methods: ELIXA (www.clinicaltrials.gov no. NCT01147250) is a randomized, double-blind, placebo-controlled, parallelgroup, multicenter study of lixisenatide in patients with T2DM and a recent ACS event. The primary aim is to evaluate the effects of lixisenatide on CV morbidity and mortality in a population at high CV risk. The primary efficacy end point is a composite of time to CV death, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for unstable angina. Data are systematically collected for safety outcomes, including hypoglycemia, pancreatitis, and malignancy. Results: Enrollment began in July 2010 and ended in August 2013; 6,068 patients from 49 countries were randomized. Of these, 69% are men and 75% are white; at baseline, the mean ± SD age was 60.3 ± 9.7 years, body mass index was 30.2 ± 5.7 kg/m2, and duration of T2DM was 9.3±8.2 years. The qualifying ACS wasamyocardial infarctionin83% and unstableangina in 17%. The study will continue until the positive adjudication of the protocol-specified number of primary CV events. Conclusion: ELIXA will be the first trial to report the safety and efficacy of a glucagon-like peptide 1 receptor agonist in people with T2DM and high CV event risk. © 2015 Elsevier Inc. All rights reserved